Advertisement

Topics

Hunter-Fleming Ltd Company Profile

20:36 EST 18th December 2018 | BioPortfolio

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenerative disorders - disorders with significant unmet medical needs. The Company’s initial focus is on neurodegenerative disorders of the central nervous system (CNS) and autoimmune disorders, areas in which the management has a proven track record in the successful development of novel compounds.Hunter-Fleming is building a broad, balanced portfolio of innovative development projects and technologies with leading academic groups and the pharmaceutical industry through licensing agreements, acquisitions, and in-house innovations which have already resulted in a proprietary series of 12 patent families.Through its access to enabling academic technologies, Hunter-Fleming has identified a potential for the design of novel second generation neuroprotective compounds. Hunter-Fleming has also established a joint venture (Hunter-Oncology Ltd) with Queen's University (Belfast) Cancer Centre to develop novel, innovative anti-cancer agents.

Location

Regus House1 Friary
Temple Quay
Bristol
BS1 6EA
United Kingdom

Contact

Phone: 44 (0) 117 900 8265
Fax: 44 (0) 117 900 8424
Email: info@hunter-fleming.com


News Articles [67 Associated News Articles listed on BioPortfolio]

Gail Fleming: 'We want to develop and invest in postgraduate pharmacy training'

After six years with Health Education England as pharmacy dean for London and the South East, Gail Fleming has joined the Royal Pharmaceutical Society to lead its directorate of education.

Lewis Katz School of Medicine at Temple University, Hunter College awarded $13.5 million NCI/NIH Grant

(Temple University Health System) The Lewis Katz School of Medicine at Temple University (LKSOM) and Hunter College of the City University of New York (Hunter) have jointly received a five-year, $13.5...

Bio-Path Holdings Appoints Dr. Jason B. Fleming to Scientific Advisory Board

HOUSTON, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...

Odors are perceived the same way by hunter-gatherers and Westerners

Previous research has shown the hunter-gatherer Jahai are much better at naming odors than Westerners. They even have a more elaborate lexicon for it. New research by language scientists show that des...

Nobilis Health Corp. (HLTH) CEO Harry Fleming on Q2 2018 Results - Earnings Call Transcript

Short stature in rainforest hunter-gatherers potentially linked to cardiac adaptations

(Penn State) African and Asian rainforest hunter-gatherers share short stature, and now an international team of researchers has shown that this is an example of convergent adaptation that may also be...

GE Healthcare and Parker Domnick Hunter Announce Distribution And Collaboration Agreements In Biopharmaceutical Purification

GE Healthcare and Parker domnick hunter, a division of Parker Hannifin announced that they have entered into an exclusive agreement for the supply and distribution of products for biopharmaceutical pu...

‘Marsquake’ hunter prepares to land on the red planet

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Fleming County Hospital Home Medical Equipment]

Oxygen

Nephrocaps [Fleming & Company, Pharmaceuticals]

NEPHROCAPS® - DIALYSIS/STRESS Vitamin Supplement

Nephrocaps-qt [Fleming & Company, Pharmaceuticals]

NEPHROCAPSQT Quick-Dissolve TabletsDIALYSIS/RENAL Vitamin

Scent-a-way anti-perspirant [Hunter's Specialties]

Scent-A-Way Extended Protection Anti-Perspirant

Nephrocaps [American Health Packaging]

NEPHROCAPS® - DIALYSIS/STRESS Vitamin Supplement

PubMed Articles [41 Associated PubMed Articles listed on BioPortfolio]

A genomic Neolithic time transect of hunter-farmer admixture in central Poland.

Ancient DNA genome-wide analyses of Neolithic individuals from central and southern Europe indicate an overall population turnover pattern in which migrating farmers from Anatolia and the Near East la...

Human Cooperation: The Hunter-Gatherer Puzzle.

In tracing the roots of human cooperation, researchers have gleaned insights from the sociality of contemporary hunter-gatherers. A new study among the Hadza, one of the few surviving foraging populat...

A comparison of the Nix Colour Sensor Pro™ and HunterLab MiniScan™ colorimetric instruments when assessing aged beef colour stability over 72 h display.

We compared the capacity for the Nix Colour Sensor Pro™ (NIX) and HunterLab MiniScan™ (HUNTER) to detect colour variation using aged (0, 3 and 5 weeks) and then displayed (0, 1, 2 and 3 d) bee...

Bow Hunter's syndrome caused by compression of the subaxial vertebral artery - surgical technique of antero-lateral decompression (video).

Bow hunter's syndrome (BHS) is a rare clinical condition. It is caused by dynamic com-pression of the vertebral artery either at the level of the transverse foramina (V2 segment) or at the atlanto-axi...

Comment on Mayock SP, Saim S, Fleming AB. In Vitro Drug Release After Crushing: Evaluation of Xtampza ER and Other ER Opioid Formulations.

Clinical Trials [25 Associated Clinical Trials listed on BioPortfolio]

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 mo...

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

This long-term study will provide Elaprase treatment to children enrolled in this study and will utilize data from both enrolled patients and Hunter Outcome Survey (HOS) patient registry d...

Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

The purpose of this non-interventional, observational study which is conducted in Mexico is to evaluate the safety profile of elaprase (idulsurfase) in participants with hunter syndrome (m...

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

The objective of this study is to evaluate the effect of anti-idursulfase IgG, IgM & IgE antibodies on idursulfase safety (measured by infusion related adverse events) between patients who...

Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.

Comparison of two methods for revascularization of the superficial femoral artery: stenting of the superficial femoral artery vs. stenting of the superficial femoral artery supplemented wi...

Companies [25 Associated Companies listed on BioPortfolio]

Hunter-Fleming Ltd

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenera...

Hunter Fleming

Hunter-Fleming is a pharmaceutical development company which specializes in bridging the product development gap between world-wide academic research and pharmaceutical marketing companies

Hunter Medical Inc.

Hunter Medical, Inc. was founded in 2013 by Lee Hunter M.D., M.B.A., a board-certified orthopaedic surgeon who specializes in surgery of the upper extremity, particularly the elbo...

Global Hunter Securities

Global Hunter Securities, LLC is a full service investment bank focusing on middle market corporate and institutional clients around the world. The firm provides insightful resear...

Hunter Wise Financial Group, LLC

Hunter Wise Financial Group, LLC is a specialized investment bank providing the highest quality level of corporate financing, merger, acquisition, divestiture and advisory services. The Company's clie...

More Information about "Hunter-Fleming Ltd" on BioPortfolio

We have published hundreds of Hunter-Fleming Ltd news stories on BioPortfolio along with dozens of Hunter-Fleming Ltd Clinical Trials and PubMed Articles about Hunter-Fleming Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hunter-Fleming Ltd Companies in our database. You can also find out about relevant Hunter-Fleming Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record